[Skip to Content]

Upstate Active Clinical Trials

Study Title:

S1701 - A Randomized Phase II Trial of Carboplatin-Paclitaxel with or without Ramucirumab in Patients with Unresectable Locally Advanced, Recurrent, or Metastatic Thymic Carcinoma

Upstate Institutional Review Board (IRB) Number:

1611637

Study/Protocol ID:

S1701

Study Phase:

II

Patient Age Group:

Adults

Principal Investigator:

Stephen L Graziano, MD

Other Information:

Open at Cancer Center, Oswego, Oneida for all procedures

Who can I contact for more information?

Name: Erinn Mcdowell, MS, CCRP
Phone: 315-464-8230
Email: mcdowele@upstate.edu

Return to Previous Page || Search Again

Top